INTERPACE BIOSCIENCES, INC. Total Assets

Quick Answer

INTERPACE BIOSCIENCES, INC. reported Total Assets of $33.84 million for the year ending 2025.

  • INTERPACE BIOSCIENCES, INC. showed an increase of +128.8% in Total Assets from 2024 to 2025.
  • This data is from INTERPACE BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
  • XBRL data for this metric is available from 2010 to 2025 (21 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2011: $116.95 million | Q3 2011: $124.21 million | Q1 2012: $108.94 million | Q2 2012: $104.82 million | Q3 2012: $106.08 million | Q1 2013: $82.80 million | Q2 2013: $77.28 million | Q3 2013: $73.21 million | Q1 2014: $65.38 million | Q2 2014: $59.46 million | Q3 2014: $62.23 million | Q1 2015: $112.61 million | Q2 2015: $107.57 million | Q3 2015: $99.29 million | Q1 2016: $56.78 million | Q2 2016: $53.51 million | Q3 2016: $45.96 million | Q1 2017: $46.98 million | Q2 2017: $53.74 million | Q3 2017: $50.39 million | Q1 2018: $53.10 million | Q2 2018: $51.36 million | Q3 2018: $49.80 million | Q1 2019: $54.38 million | Q2 2019: $50.33 million | Q3 2019: $74.67 million | Q1 2020: $78.51 million | Q2 2020: $78.43 million | Q3 2020: $50.70 million | Q1 2021: $43.86 million | Q2 2021: $43.19 million | Q3 2021: $40.31 million | Q1 2022: $38.36 million | Q2 2022: $35.49 million | Q3 2022: $15.29 million | Q3 2023: $14.25 million | Q1 2025: $14.49 million | Q2 2025: $12.34 million | Q3 2025: $12.04 million.
  • Over the full 21 years of available data (2010 to 2025), INTERPACE BIOSCIENCES, INC.'s Total Assets has declined by 72.8%.
  • Historical annual values: Fiscal year 2025: $33.84 million | Fiscal year 2024: $14.79 million | Fiscal year 2024: $14.04 million | Fiscal year 2024: $12.97 million | Fiscal year 2024: $12.14 million | Fiscal year 2023: $13.12 million | Fiscal year 2023: $16.06 million | Fiscal year 2023: $15.98 million | Fiscal year 2022: $15.98 million | Fiscal year 2021: $38.43 million | Fiscal year 2020: $45.68 million | Fiscal year 2019: $51.54 million | Fiscal year 2018: $48.44 million | Fiscal year 2017: $53.60 million | Fiscal year 2016: $41.78 million | Fiscal year 2015: $67.71 million | Fiscal year 2014: $115.91 million | Fiscal year 2013: $69.06 million | Fiscal year 2012: $78.45 million | Fiscal year 2011: $113.38 million | Fiscal year 2010: $124.39 million.
  • Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: